Page last updated: 2024-10-26

fenbendazole and Leukemia, Promyelocytic, Acute

fenbendazole has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Fenbendazole: Antinematodal benzimidazole used in veterinary medicine.
fenbendazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted at positons 2 and 5 by (methoxycarbonyl)amino and phenylsulfanediyl groups, respectively. A broad-spectrum anthelmintic, it is used, particularly in veterinary medicine, for the treatment of nematodal infections.

Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
KalantarMotamedi, Y1
Ejeian, F1
Sabouhi, F1
Bahmani, L1
Nejati, AS1
Bhagwat, AM1
Ahadi, AM1
Tafreshi, AP1
Nasr-Esfahani, MH1
Bender, A1

Other Studies

1 other study available for fenbendazole and Leukemia, Promyelocytic, Acute

ArticleYear
Transcriptional drug repositioning and cheminformatics approach for differentiation therapy of leukaemia cells.
    Scientific reports, 2021, 06-15, Volume: 11, Issue:1

    Topics: Cheminformatics; Drug Repositioning; Fenbendazole; Humans; Leukemia, Promyelocytic, Acute; Tretinoin

2021